Pancreatic cancer kills three in four people within the first year. But new research is offering hope to people in years to ...

Using a new technology and computational method, researchers from Fred Hutch Cancer Center and The University of Texas MD ...

Early diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of ...

One in six patients in phase II oncology clinical trials received a treatment that was eventually approved by the FDA, ...

OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced a collaboration with Gustave Roussy, the first European cancer center, to ...

This new review article highlights the crucial role of GATA6, a transcription factor, in pancreatic ductal adenocarcinoma ...

Early diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of lung-cancer-related mortality, extend disease-free survival, and allow patients to live ...

The Providence Cancer Center at Alaska Medical Center in Anchorage, part of Renton, Wash.-based Providence, will become the first hospital in Alaska to offer the targeted prostate cancer therapy, ...

“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...

Scientists at Oregon Health and Science University (OHSU) have developed a new blood test for pancreatic cancer, one of the ...

BioSymetrics is a leading AI-powered drug discovery and data analytics company, focusing on phenotype-based insights to ...